DIO2 and obesity disorder: To determine the contribution of elevated Dio2 in GC-induced hyperphagia and obesity, an AAV-mediated CRISPR-Cas9 approach was employed to knock down Dio2 in the mediobasal hypothalamus (MBH), before mice were challenged with Cort for 4 weeks.